Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.75 |
| ▸ | MEN1 | O00255 | 4/20 | 0.73 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.73 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.73 |
| ▸ | HSP90AB1 | P08238 | 1/20 | 0.73 |
| ▸ | PPIA | P62937 | 3/20 | 0.70 |
| ▸ | AMY1A | P0DUB6 | 1/20 | 0.69 |
| ▸ | MAPT | P10636 | 1/20 | 0.66 |
| ▸ | GFER | P55789 | 1/20 | 0.66 |
| ▸ | CHIA | Q9BZP6 | 1/20 | 0.65 |
| ▸ | THRB | P10828 | 1/20 | 0.65 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.65 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6670019 | 0.96 | ALDH1A1 (0.70) | ALDH1A1MEN1KMT2AHSP90AA1HSP90AB1 | |
| SCHEMBL2871844 | 0.87 | ALDH1A1 (0.69) | ALDH1A1MEN1KMT2AHSP90AA1HSP90AB1 | |
| SCHEMBL21795038 | 0.87 | KMT2A (0.80) | ALDH1A1MEN1KMT2AHSP90AA1HSP90AB1 | |
| SCHEMBL2871247 | 0.85 | CHIA (0.80) | ALDH1A1MEN1KMT2AHSP90AA1HSP90AB1 | |
| SCHEMBL5565268 | 0.83 | ALDH1A1 (0.68) | ALDH1A1MEN1KMT2AHSP90AA1HSP90AB1 | |
| SCHEMBL12010930 | 0.83 | HSP90AA1 (0.83) | ALDH1A1MEN1KMT2AHSP90AA1HSP90AB1 | |
| Sulfamethoxazole SCHEMBL20456610 | 0.82 | ALDH1A1 (0.89) | ALDH1A1MEN1KMT2AHSP90AA1HSP90AB1 | |
| SCHEMBL31469213 | 0.81 | ALDH1A1 (0.73) | ALDH1A1MEN1KMT2AHSP90AA1HSP90AB1 | |
| SCHEMBL5339369 | 0.81 | ALDH1A1 (0.57) | ALDH1A1MEN1KMT2AHSP90AA1HSP90AB1 | |
| SCHEMBL12879697 | 0.81 | ALDH1A1 (0.77) | ALDH1A1MEN1KMT2AHSP90AA1HSP90AB1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 49 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-110441447-B | Deuterated sulfamethoxazole-d4Method of synthesis of | 雅安职业技术学院 | 2022-04-08 | — | — | CN | claimed |
| CN-107991409-B | Method for simultaneously measuring 12 sulfonamides in blood plasma by adopting high-efficiency synthetic phase chromatography | 中国医学科学院肿瘤医院 | 2020-04-24 | — | — | CN | claimed |
| CN-110003128-A | A kind of sulfamethoxazole and its synthetic method of stable isotope labeling | 上海安谱实验科技股份有限公司 | 2019-07-12 | — | — | CN | claimed |
| US-20160325012-A1 | GEL-FORMING AGENT COMPRISING SULFA AGENT AND CHITOSAN AGENT AND HAVING POWDERED DOSAGE FORM | GREENEVER (JP) | 2016-11-10 | — | — | US | claimed |
| EP-3087990-A1 | GEL-FORMING AGENT CONTAINING SULFONAMIDE AND CHITOSAN AND HAVING A POWDERED DOSAGE FORM | Greenever (JP) | 2016-11-02 | — | — | EP | claimed |
| CN-120064476-A | Solid phase extraction-ultra-high performance liquid chromatography-tandem mass spectrometry rapid determination method for various antibiotics in human urine | 复旦大学 | 2025-05-30 | — | — | CN | disclosed |
| WO-2025088151-A1 | ENHANCED METABOLIC MEDIUM FOR CULTURING PLURIPOTENT STEM CELLS | UNIVERSITY OF COPENHAGEN (DK) | 2025-05-01 | — | — | WO | disclosed |
| CN-119889726-A | Semen quality prediction method and system based on random forest | 深圳市疾病预防控制中心(深圳市卫生监督局、深圳市卫生检验中心、深圳市预防医学研究所) | 2025-04-25 | — | — | CN | disclosed |
| WO-2025036962-A1 | METHOD AND SYSTEM FOR WASTEWATER TREATMENT AND NUTRIENT RECOVERY | EAWAG EIDG. ANSTALT FÜR WASSERVERSORGUNG, ABWASSERREINIGUNG UND GEWÄSSERSCHUTZ (CH) | 2025-02-20 | — | — | WO | disclosed |
| EP-4509470-A1 | METHOD AND SYSTEM FOR WASTEWATER TREATMENT AND NUTRIENT RECOVERY | EAWAG Eidg. Anstalt für Wasserversorgung Abwasserreinigung und Gewässerschutz (CH) | 2025-02-19 | — | — | EP | disclosed |
| WO-2025021378-A1 | METHOD TO DETECT CONTAMINATION WITH ANTIBIOTIC METABOLITES AND METHOD TO REDUCE OR AVOID DEVELOPMENT OF ANTIBIOTIC RESISTANCE | TECHNOLOGICAL UNIVERSITY DUBLIN (IE) | 2025-01-30 | — | — | WO | disclosed |
| US-11845681-B2 | Process and plant for treating wastewater containing micropollutants of pharmaceutical origin | COCKERILL MAINTENANCE & INGENIERIE S.A. (BE) | 2023-12-19 | — | — | US | disclosed |
| US-20030092754-A1 | External preparation for skin diseases containing nitroimidazole | SHOEI CO., LTD. (JP) | 2003-05-15 | — | — | US | disclosed |
| US-6416546-B1 | Medical device and production method thereof | UNITIKA LTD. (JP) | 2002-07-09 | — | — | US | disclosed |
| EP-1206937-A1 | NITROIMIDAZOLE EXTERNAL PREPARATIONS FOR DERMATOSIS | SHOEI CO., LTD. (JP) | 2002-05-22 | — | — | EP | disclosed |
| CN-1316897-A | Dosage form comprising liquid formulation | ALZA CORP (US) | 2001-10-10 | — | — | CN | disclosed |
| CN-1211928-A | Method for increasing solubility of substantially water-insoluble compounds | UNION CARBIDE CHEM PLASTIC (US) | 1999-03-24 | — | — | CN | disclosed |
| EP-0882461-A2 | Medical device and production method thereof | UNITIKA LTD. (JP) | 1998-12-09 | — | — | EP | disclosed |
| CN-1191476-A | Oral delivery of discrete units | ALZA CORP (US) | 1998-08-26 | — | — | CN | disclosed |
| EP-0055609-A1 | Composition for coelomic administration, its preparation, and ingredients for use therein | SHIONOGI & CO., LTD. (JP) | 1982-07-07 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030092754-A1 | External preparation for skin diseases containing nitroimidazole | IL4I1, NSD1, CUTA | ALDH1A1 776/4885MEN1 3791/4885KMT2A 805/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.